Chai Discovery Raises $400 Million Series C at $3.8 Billion Valuation as Pfizer, Lilly and Novartis Deals Pile Up
AI drug-design startup Chai Discovery raised $400 million at a $3.8 billion valuation, nearly tripling its worth in seven months as Pfizer, Eli Lilly and Novartis sign on.